Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.

PloS one - 1 Jan 2016

Liu Jingjing, Sieuwerts Anieta M, Look Maxime P, van der Vlugt-Daane Michelle, Meijer-van Gelder Marion E, Foekens John A, Hollestelle Antoinette, Martens John W M

Abstract excerpt

Increased APOBEC3B mRNA levels are associated with a hypermutator phenotype and poor prognosis in ER-positive breast cancer patients. In addition, a 29.5 kb deletion polymorphism of APOBEC3B, resulting in an APOBEC3A-B hybrid transcript, has been associated with an increased breast cancer risk and the hypermutator phenotype. Here we evaluated whether the APOBEC3B deletion polymorphism also associates with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytidine Deaminase
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Kaplan-Meier Estimate

Share to Minor Histocompatibility Antigens

Share to Neoplasm Grading

Share to Proportional Hazards Models

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 27552096
DOI: 10.1371/journal.pone.0161731
PMCID: PMC4995039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.PMID 27552096Read ↗

The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European populationSemantic proximity Read ↗

APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.Semantic proximity Read ↗

Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.Semantic proximity Read ↗

Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.Semantic proximity Read ↗

Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.Semantic proximity Read ↗

The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population.Semantic proximity Read ↗

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer.Semantic proximity Read ↗

APOBEC3A/B deletion polymorphism and endometrial cancer risk.Semantic proximity Read ↗

APOBEC3A/B deletion polymorphism and cancer risk.Semantic proximity Read ↗

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.Semantic proximity Read ↗

Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.Semantic proximity Read ↗

Loss of c-met protooncogene in primary and metastatic sites of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.